Comparative studies with exendin(9-39)amide and the novel (Pro(3))GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis

Finbarr O'Harte, Victor Gault, P Harriott, BD Green, Peter Flatt

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)548
JournalDiabetologia
Volume45
Issue numberSuppl.
Publication statusPublished - Aug 2002

Bibliographical note

38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, BUDAPEST, HUNGARY, SEP
01-05, 2002

Cite this